SeaSpine gets FDA clearance for NanoMetalent surface tech

SeaSpine received FDA clearance to market its NanoMetalene surface technology for interbody devices, according to a Dec. 15 news release.

Advertisement

NanoMetalene technology incorporates a submicron layer of commercially pure titanium bonded to a PEEK implant with a high-energy, low temperature process, the release said. It’s designed to provide a molecularly bonded layer of bone-friendly titanium on the implant.

The clearance allows SeaSpine to describe NanoMetalene as “providing a microscopic roughened surface with nano-scale features” and updates indications for use across the 12 implant systems, which it was previously applied. SeaSpine expects to use NanoMetalene with more implant systems over the next year.

Read more details here.

More articles on devices:
How CMS’ changes will affect spine surgeons in 2021 — Prior authorization, fee cuts & more
Former orthopedic practice owner gets 5 years in prison for illegally prescribing opioids
Surgeons’ brand exceeds patient outcomes — How you should build your practice’s brand

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.